£2m Cancer Boost For Kent
2 April 2017, 10:16 | Updated: 2 April 2017, 10:21
The NHS is investing nearly £2 million to modernise radiotherapy in Kent.
The money is being spent on replacing the linear accelerator which allows doctors to target specific tumours more accurately.
NHS England has confirmed that Maidstone and Tunbridge Wells NHS Trust (MTW) will be given £1.8 million in funding to modernise radiotherapy care.
Jim Lusby, Deputy Chief Executive at MTW, said: "We are delighted by this funding announcement from NHS England which is a massive boost to our Kent Oncology Centre and will ensure we continue to provide optimum treatment, care and support to cancer patients."
David Fitzgerald, General Manager for Cancer and Haematology, MTW, commented: "This funding is a big step forward for Kent Oncology and will allow us to continue to deliver the most advanced radiotherapy treatments to the population of Kent, Medway and East Sussex."
The new LINAC will allow radiotherapy staff to target tumours which can vary in position during treatment, and will help to deliver treatment quickly and accurately while avoiding healthy tissues and organs.
Around four in 10 of all NHS cancer patients are treated with radiotherapy, which typically uses high-energy radiation from a LINAC. Radiotherapy is one of the three main cancer treatments, alongside cancer surgery and chemotherapy.
The Kent Oncology Centre treats over 300 new patients every month and cares for a population of 1.8 million people.